Gamble Jones Investment Counsel Gilead Sciences, Inc. Transaction History

Gamble Jones Investment Counsel

$1.33 Billion
Q4 2022

A detailed history of Gamble Jones Investment Counsel transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Gamble Jones Investment Counsel holds 2,737 shares of GILD stock, worth $252,926. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,737

Previous 2,737 -0.0%

Holding current value

$252,926

Previous $169,000 38.46%

% of portfolio

0.02%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	BUY	$59.54 - $68.01 $162,960 - $186,143	2,737 New	2,737 $169,000
Q1 2022 May 02, 2022	SELL	$57.92 - $72.58 $173,007 - $216,796	-2,987 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$64.88 - $73.64 $40,095 - $45,509	-618 Reduced 17.14%	2,987 $217,000
Q3 2021 Nov 09, 2021	SELL	$67.69 - $73.03 $6,769 - $7,303	-100 Reduced 2.7%	3,605 $252,000
Q1 2021 May 10, 2021	SELL	$60.0 - $68.46 $144,000 - $164,303	-2,400 Reduced 39.31%	3,705 $239,000
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $42,487 - $48,412	-750 Reduced 10.94%	6,105 $356,000
Q1 2020 May 08, 2020	SELL	$62.63 - $80.22 $21,607 - $27,675	-345 Reduced 4.79%	6,855 $512,000
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $14,295 - $15,724	-232 Reduced 3.12%	7,200 $468,000
Q3 2019 Nov 04, 2019	SELL	$62.51 - $69.0 $128,458 - $141,795	-2,055 Reduced 21.66%	7,432 $471,000
Q2 2019 Aug 20, 2019	SELL	$61.87 - $69.38 $67,747 - $75,971	-1,095 Reduced 10.35%	9,487 $641,000
Q1 2019 May 02, 2019	SELL	$62.53 - $70.05 $62,530 - $70,050	-1,000 Reduced 8.63%	10,582 $688,000
Q4 2018 Feb 04, 2019	SELL	$60.54 - $79.0 $245,792 - $320,740	-4,060 Reduced 25.96%	11,582 $724,000
Q3 2018 Nov 06, 2018	SELL	$71.28 - $78.92 $22,096 - $24,465	-310 Reduced 1.94%	15,642 $1.21 Million
Q2 2018 Aug 03, 2018	SELL	$64.88 - $75.68 $75,455 - $88,015	-1,163 Reduced 6.8%	15,952 $1.13 Million
Q1 2018 May 10, 2018	SELL	$72.84 - $88.8 $59,801 - $72,904	-821 Reduced 4.58%	17,115 $1.29 Million
Q4 2017 Feb 06, 2018	SELL	$71.15 - $83.52 $66,240 - $77,757	-931 Reduced 4.93%	17,936 $1.29 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1.36 Million - $1.61 Million	18,867	18,867 $1.53 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamble Jones Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Gamble Jones Investment Counsel with notifications on news.

Account

Gamble Jones Investment Counsel Gilead Sciences, Inc. Transaction History